Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
Silvia Stringhini, María-Eugenia Zaballa, Javier Perez‐Saez, Nick Pullen, Carlos de Mestral, Attilio Picazio, Francesco Pennacchio, Ania Wisniak, Aude Richard, Hélène Baysson, Andrea Loizeau, Jean-François Balavoine, Didier Trono, Didier Pittet, Klara M. Posfay‐Barbe, Antoine Flahault, François Chappuis, Omar Kherad, Nicolas Vuilleumier, Laurent Kaiser, Andrew S. Azman, Idris Guessous
Topics & Concepts
SeroprevalenceVirologyPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodyMedicineSerologyImmunologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19